Assurex Health, Ltd

Name

Assurex Health, Ltd

Legal name

Myriad Genetics, Inc./Assurex Health, Inc.

Website

https://assurexhealth.com

Company type

Public

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmacogenomic Diagnostic Testing

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Pharmacogenomics (PGx) Decision Support (HLAAANAB)

akta.pro secondary industry

Companion Diagnostics (CDx) & Therapy Selection Assays (HLAAALAF)

Keywords

• Pharmacogenomic testing
• Mental health medications
• Genetic testing services
• Psychiatric medication analysis
• DNA diagnostic testing

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Laboratory Testing Services: GeneSight pharmacogenomic testing services billed through insurance. Healthcare providers order the test, patients provide samples via cheek swab, and results are delivered to providers. Revenue generated from insurance reimbursements and patient co-pays based on coverage.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Assurex Health provides the GeneSight pharmacogenomic testing service, which analyzes clinically important genetic variations in a patient's DNA to predict how they may respond to medications commonly prescribed for depression, anxiety, ADHD, and other psychiatric conditions. The flagship GeneSight Psychotropic test classifies 60+ mental health medications into gene-drug interaction categories, with samples collected via cheek swab and results delivered to the prescribing clinician. The offering is supplemented by the GeneSight MTHFR Test for folate metabolism and the GeneSight at Home collection option.

Product overview

Assurex Health, operating as GeneSight, offers a pharmacogenomic testing portfolio centered on its flagship GeneSight Psychotropic test. The core product analyzes genetic variations affecting medication metabolism to guide mental health treatment decisions across depression, anxiety, ADHD, and related conditions. This is supplemented by the GeneSight MTHFR Test, which assesses folate metabolism gene variants, and GeneSight at Home, a patient-friendly DNA collection option. The company is a subsidiary of Myriad Genetics, Inc. (dba Myriad Neuroscience).

Differentiator

Problem solved

Functional benefit

Brands

• GeneSight: Pharmacogenomic test brand analyzing clinically important genetic variations in DNA to inform healthcare providers about medication responses for depression, anxiety, ADHD, and other psychiatric conditions.

Products and services

• GeneSight Psychotropic

Quantifiable outcome

• Patients who received GeneSight testing saved over $1,000 in total annual medication costs compared to traditional approaches
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Myriad Genetics, Inc.coreStrategic or Co-development PartnerAssurex Health, Ltd. operates as a subsidiary of Myriad Genetics under the dba Myriad Neuroscience. GeneSight is a product within the Myriad Genetics portfolio of genetic tests, sharing branding and infrastructure with the parent company.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Quest Diagnostics: National clinical laboratory offering pharmacogenomic and specialty testing, with the scale and payer relationships that set the competitive context for niche PGx providers like GeneSight.
• Labcorp: Major clinical laboratory network with a broad PGx menu and national payer contracts, representing the incumbent alternative that GeneSight competes against for clinician test orders.
• Myriad Genetics: Parent company and broader genetic testing platform with a multi-product portfolio including hereditary cancer, prenatal, and pharmacogenomic tests, providing corporate context and shared infrastructure for GeneSight.
• Mayo Clinic Laboratories: A large reference laboratory offering a wide menu of pharmacogenomic and clinical tests, competing broadly in the lab services space that GeneSight occupies.

Direct peers

• Coriell Life Sciences: Coriell Life Sciences provides pharmacogenomic decision support tools and medication management services, addressing similar use cases of guiding drug selection based on patient genetics.
• Genomind: Genomind offers the Genecept Assay, a pharmacogenomic test for mental health medications, directly competing with GeneSight in the psychiatric PGx category with overlapping prescriber audiences.
• YouScript (by Translational Software): YouScript delivers PGx decision support and clinical interpretation services to healthcare providers, directly overlapping with GeneSight's clinician-facing medication selection workflow.
• Genelex: Genelex offers the YouScript PGx platform and pharmacogenomic testing services focused on medication safety and efficacy, comparable in service model and target prescribers.

Emerging players

• Invitae: Genetic testing company with expanding pharmacogenomic and mental health offerings, representing an emerging platform player that could broaden into the psychiatric PGx segment.
• Color Health: Technology-enabled genetic testing and population health company expanding into medication management and hereditary risk, with overlapping capabilities in clinician-ordered genetic testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/GeneSight
• YouTubeyoutube.com/c/genesight%20
• Facebookfacebook.com/GeneSight
• LinkedInlinkedin.com/company/assurex-health-ltd
• Instagraminstagram.com/GeneSight

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Assurex Health, Ltd